Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 44, Issue 1, 2015, Pages 8-12

  Krol, A ^a,b   Garred, P ^a,b   Heegaard, N H H ^c   Christensen, A F ^d   Hetland, M L ^b,e   Stengaard Pedersen, K ^f   Junker, P ^d   Madsen, H O ^a,b   Lottenburger, T ^g   Ellingsen, T ^f,g   Andersen, L S ^h   Hansen, I ^f   Pedersen, J K ^h   Svendsen, A J ^d   Tarp, U ^f   Podenphant J ⁱ   Lindegaard, H ^d   Ostergaard M ^b,e   Horslev Petersen K ^h   Jacobsen, S ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g SILKEBORG REGIONAL HOSPITAL   (Denmark)

^h University Hospital of Southern Denmark   (Denmark)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTHROPATHY; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; EROSIVE JOINT DISEASE; FEMALE; FOOT RADIOGRAPHY; HAND; HAND RADIOGRAPHY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; WRIST RADIOGRAPHY; ARTHRITIS, RHEUMATOID; BLOOD; IMMUNOLOGY; JOINT; MIDDLE AGED; PREVALENCE; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; JOINTS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; RHEUMATOID FACTOR; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SMOKING; YOUNG ADULT;

EID: 84920830384     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.918651     Document Type: Article

References (15)

1. van der Heijde DM, van Riel PL, van Rijswijk MH, van de Putte LB. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988;17:284-92.
2. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene-environment effects in anti-CCP-positive rheumatoid arthritis - a nationwide case-control study in Denmark. Arthritis Rheum 2007;56:1446-53.
3. Naranjo A, Toloza S, Guimaraes da Silveira I, Lazovskis J, Hetland ML, Hamoud H, et al. Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database. Clin Exp Rheumatol 2010;28:820-7.
4. Newkirk MM. Rheumatoid factors: what do they tell us? J Rheumatol 2002;29:2034-40.
5. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808.
6. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117-21.
7. Söderling MK, Petersson IF, Geborek P. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand J Rheumatol 2012;41:1-9.
8. Hetland M, Steengaard-Pedersen K, Junker P, Lottenburger T, Ellingesen T, Andersen LS, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis. An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54:1401-9.
9. Vasiliauskiene L, Wiik A, Hoier-Madsen M. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:459-66.
10. Kimura A, Sasazuki T. Eleventh International Histocompatibility workshop reference protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki M, editors. HLA 1991. Oxford: Oxford University Press, 1992.
11. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008;47:399-402.
12. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2007;65:366-371.
13. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41
14. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
15. Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002;46:640-6.